Influence of input multiplicity of infection on the antiviral activity of interferon

Insights

Interferon offers limited antiviral protection, especially at high multiplicities of infection (m.o.i.). Its effectiveness diminishes with increased viral load, only delaying, not preventing, cell death.

Area of Science:

  • Virology
  • Immunology
  • Cell Biology

Background:

  • Interferons are crucial cytokines in the innate immune response against viral infections.
  • Understanding the factors influencing interferon efficacy is vital for developing effective antiviral strategies.

Purpose of the Study:

  • To investigate the impact of the input multiplicity of infection (m.o.i.) on the antiviral activity of interferon.
  • To elucidate the relationship between interferon concentration, m.o.i., and the duration of antiviral protection.

Main Methods:

  • Cells were treated with interferon and subsequently infected with various viruses (vaccinia, herpes, Echo, vesicular stomatitis virus) at different multiplicities of infection (m.o.i.).
  • The cytopathogenic effects and cell survival were monitored to assess antiviral protection.
  • Potential mechanisms, including viral subtype selection and interferon induction, were explored.

Main Results:

  • Interferon's antiviral activity was highly dependent on the input m.o.i., with protection failing at m.o.i. > 1.
  • Lower m.o.i. required less interferon for protection, but this protection was transient and inversely related to m.o.i.
  • The duration of interferon's antiviral effect also decreased with increasing m.o.i.

Conclusions:

  • Interferon treatment does not prevent cell death upon viral infection, particularly at higher m.o.i.
  • Interferon primarily inhibits viral replication to a limited extent, causing a delay in inevitable cell death.

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...